))
Can psychedelics overcome the complex legal challenges to provide wider access to their benefits?
Manage episode 439152187 series 3452217
Contenido proporcionado por Dykema's Cannabis Industry Group. Todo el contenido del podcast, incluidos episodios, gráficos y descripciones de podcast, lo carga y proporciona directamente Dykema's Cannabis Industry Group o su socio de plataforma de podcast. Si cree que alguien está utilizando su trabajo protegido por derechos de autor sin su permiso, puede seguir el proceso descrito aquí https://es.player.fm/legal.
Psychedelics hold immense promise for disrupting the consumer wellness space, and present a potentially lucrative opportunity for investors. But before they can fully capitalize on this potential, psychedelic brands will need to navigate the significant legal hurdles before them. Brett Gelbord sits down with Evan Eneman, founder and CEO of The Sands Lane Foundation, to explore the benefits of psychedelics, the investment opportunities they offer, and the complex legal framework that could impact their growth and success
To hear more episodes, be sure to subscribe to Dykema’s YouTube channel, the Cannabis Law Blog, or by searching “A Higher Law” wherever you get your podcasts.
Find more on Brett here.
Find more on Evan and The Sands Lane Foundation here.
To hear more episodes, visit DykemaPodcast.com, our YouTube page, or search “A Higher Law” wherever you get your podcasts.
Subscribe to Dykema’s Cannabis Law Blog
Learn more about Dykema’s cannabis group
Follow Dykema on LinkedIn
27 episodios
Compartir
